Giuseppe Matarese

41PUBLICATIONS
139CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Dec 17, 2025
Treg Susceptibility to Cladribine-Induced Depletion Correlates With Therapy Response in Patients With Multiple Sclerosis.

Ilenia Cammarata, Giorgia Sartori, Tiziano Giacomelli

|Jun 12, 2025
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis.

Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo

|Apr 04, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.

Rosella Mechelli, Renato Umeton, Gianmarco Bellucci

|Feb 21, 2025
B cell immunometabolism in health and disease.

Eleonora Martinis, Silvia Tonon, Alessandra Colamatteo

|Jan 15, 2025
CD4<sup>+</sup>FOXP3Exon2<sup>+</sup> regulatory T cell frequency predicts breast cancer prognosis and survival.

Clorinda Fusco, Francesca Di Rella, Antonietta Liotti

|Aug 13, 2024
Randomised controlled trial of intermittent calorie restriction in people with multiple sclerosis.

Laura Ghezzi, Valeria Tosti, Lisa Shi

Pageof 7

Frequent Collaborators

6 joint publications

Mario Galgani

5 joint publications

Paola de Candia

4 joint publications

Alessandra Colamatteo

4 joint publications

Antonio Porcellini